Toggle light / dark theme

THIS IS HUGE!! New study suggests that aging could be preventable, delayable and even reversible! A recent study published in Engineering proposes a new theory called pro aging metabolic reprogramming (PAMRP)


Aging is a complex process that has long puzzled scientists. A recent study published in Engineering proposes a new theory called pro-aging metabolic reprogramming (PAMRP), which could change our understanding of aging.

The traditional debate on aging has centered around whether it is a programmed process or a result of stochastic events. The PAMRP theory combines these two perspectives. It suggests that aging is driven by degenerative metabolic reprogramming over time. This involves both the buildup of pro-aging substrates (PASs) through and the emergence of pro-aging triggers (PATs). The combination of PASs and PATs leads to metabolic reprogramming, which in turn causes cellular and genetic reprogramming, ultimately resulting in the aging process.

Metabolism plays a crucial role in the PAMRP theory. As organisms age, there are significant changes in metabolic pathways, such as shifts in energy production and nutrient utilization. These changes initially serve as an adaptive mechanism but can become maladaptive over time, contributing to aging. The theory also distinguishes between different types of metabolic reprogramming, such as adaptive and adverse, and between regenerative and degenerative processes.

Summary: Researchers identified a brain circuit involving the amygdala and hippocampus that predicts resilience to stress in mice. Mice with disrupted neural communication in this circuit struggled to seek rewards, but activating the neurons restored resilience and improved decision-making.

Using chemogenetics, the team stimulated brain activity in less resilient mice, which then displayed normal behavior and sought sweetened water. This breakthrough suggests potential new, non-invasive treatments for chronic stress and depression in humans, with researchers now exploring similar patterns in human brains.

Autism is a neurodevelopmental disorder characterized by difficulties in communication and social behavior. Approximately 20% of cases are linked to a specific genetic mutation, but the origin of the remaining 80%, known as idiopathic autism, remains a mystery.

A team of scientists led by Drs. Raúl Méndez and Xavier Salvatella at the Institute for Research in Biomedicine (IRB Barcelona) has identified a that explains why certain alternations of the neuronal protein CPEB4 are associated with idiopathic autism.

The study is based on previous work published in 2018 that identified CPEB4 as a key protein in the regulation of neuronal proteins related to autism.

The integration of quantum computing into personalized medicine holds great promise for revolutionizing disease diagnosis, treatment development, and patient outcomes. Quantum computers have the potential to process vast amounts of genetic data much faster than classical computers, enabling researchers to identify patterns and correlations that may not be apparent with current technology. This could lead to breakthroughs in understanding the genetic basis of complex diseases and developing targeted treatments.

Quantum computing also has the potential to revolutionize medical imaging by enabling the simulation of complex magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Quantum algorithms can efficiently process large-scale imaging data, enabling researchers to reconstruct high-resolution images that reveal subtle details about tissue structure and function. This has significant implications for disease diagnosis and treatment, where accurate imaging is critical for developing effective treatments.

The use of quantum computing in personalized medicine raises important ethical considerations, such as concerns about privacy and informed consent. The ability to rapidly analyze large amounts of genetic data also raises questions about how this information should be used and shared with patients. Regulatory frameworks will play a crucial role in shaping the development and deployment of quantum computing in personalized medicine, balancing the need to promote innovation with the need to protect patient safety and privacy.

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most challenging genetic disorders and diseases.

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a Nobel Prize-winning gene-editing tool, already widely used by scientists to cut and modify DNA sequences to turn genes on and off or insert new DNA that can correct abnormalities. CRISPR uses an enzyme known as Cas9 to cut and alter DNA.

Engineers at the USC Alfred E. Mann Department of Biomedical Engineering have now developed an update to the tool that will allow CRISPR technology to be even more powerful with the help of focused ultrasound.

The Armenians, a population in Western Asia historically native to the Armenian Highlands, were long thought to be descendants of Phrygian settlers from the Balkans. This theory, rooted primarily in the writings of the Greek historian Herodotus, stemmed from his observation that Armenians serving in the Persian army were armed in a manner similar to the Phrygians. Linguists have also bolstered this theory, noting linguistic connections between the Armenian language and the Thraco-Phrygian subgroup of Indo-European languages.

But the first whole-genome study is challenging this long-held belief, revealing no significant genetic link between Armenians and the populations in the Balkan region. The study compares newly generated modern Armenian genomes and published genetic data of ancient individuals from the Armenian highlands with both modern and ancient genomes from the Balkans.

A novel breakthrough, leveraging CRISPR gene-editing technology, is revolutionizing how scientists study sEVs. This innovative approach, known as CIBER (CRISPR-assisted individually barcoded sEV-based release regulator), enables researchers to investigate thousands of genes simultaneously.

By tagging sEVs with unique RNA “barcodes,” CIBER offers unparalleled insights into the molecular processes regulating sEV release, setting the stage for advancements in biotechnology and disease treatment.

Extracellular vesicles, which include sEVs, are small, membrane-enclosed particles released by cells into their surroundings. Their size, origin, and cargo determine their classification. sEVs, typically 30–200 nanometers in diameter, are among the smallest but most intriguing members of this group. These vesicles transport biomolecules—such as RNA, proteins, and lipids —between cells, acting as communication messengers.

Has human evolution come to a standstill? Advances in technology and medicine have radically changed the way we live, but could they be changing the course of our genetic future? The surprising truth behind how modern progress may be changing our biology — and what it means for our survival.